References

Patents and Copyrights

• U.S. Patent #5,120,833. Method of producing grafts
• U.S. Patent #5,401,730. Method for reducing platelet aggregation
• U.S. Copyright registration # TXu 726-138. Platelet Aggregation Analysis

Publications

1. Kaplan A, Sauvage LR, Kaplan S, Marcoe KF, Mungin D, Wu HD, Walker MW. A new method for measuring permeability of bio-impregnated textile grafts. J Applied Biomaterials 1990; 1:127-136.
2. Patel M, Kaplan A, Sauvage LR, Wu HD, Kaplan S, Usui Y, Walker MW. Comparative evaluation of the elasticity and flexibility of bioimpregnated knitted grafts. Ann Vasc Surg 1992; 6:127-33.
3. Saad E, Kaplan S, El-Massry S, Kaplan A, Marcoe KF, Zammit M, Fisher LD, Sauvage LR. Platelet aggregometry can accurately predict failure of externally supported knitted Dacron femoropopliteal bypass grafts. J Vasc Surg 1993;18:587-95.
4. Kaplan S, Kaplan A, Marcoe KF, Gey GO, Schiller H, Roby PV, Fisher LD, El-Massry S, Sauvage LR. The platelet aggregation score and its correlation to ß-thromboglobulin and platelet factor 4 levels. Clin Appl Thrombosis/Hemostasis 1995;1:135-141.
5. Kaplan S, Kaplan A, Marcoe KF, Hammond WP, Fischer LD, Sauvage LR. Citric acid enhances the antithrombotic effect of aspirin in many aspirin-resistant subjects. Clin Appl Thrombosis/Hemostasis, 1997, 3(1), 54-57.
6. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. Identification of potential predisposition to clinical atherosclerosis is: A concept based on integration of significant blood parameters with platelet aggregation scores. Clin Appl Thrombosis/Hemostasis, 1997, 3(3) :174-182.
7. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. Modified laboratory technique for measuring platelet aggregability. Clin Appl Thrombosis/Hemostasis, 1997, 3(3) :196-202.
8. Hammond WP, Wun T, Kaplan A, Kaplan S, Paglieroni T, Kaushansky K, Foster DC. High concentrations of thrombopoietin activate platelets in vitro. Clin Appl Thrombosis/Hemostasis, 1998, 4(3) : 170-178.
9. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. The effect of hematopoietic growth factors on platelet aggregability. Clin Appl Thrombosis/Hemostasis, 1998, 4(4) : 238-242.
10. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR. Assessment of predictive power of the clinical atherosclerosis predisposition factor for identification of people at risk for developing cardiovascular disease. Submitted for publication.
11. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. Multifactorial risk assessment of clinical atherosclerosis in women based on integration of fibrinogen and other hematological risk markers. Blood Coagulation and Fibrinolysis. 1999;10:119.
12. Kaplan S, Kaplan A, Marcoe K and Sauvage L. Ticlopidine, alka-seltzer, or a combination of citric acid with aspirin: effect on platelet aggregation in individuals with an insufficient response to aspirin alone. Clin Appl Thrombosis/Hemostasis, 2000, 6(4) : 222-225.